COLL vs MOS · P/E 17, rev $181.9M vs P/E 161, rev $11.12B
Collegium Pharmaceutical Inc (COLL) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the COLL and MOS stock pages for the full models.
Not investment advice.